10:11:19 AM PDT - Sunday, May 19th, 2019

Pfizer's Bavencio+Inlyta Combo Gets FDA Nod for Kidney Cancer  

By Editor - Wed May 15, 10:04 am

Pfizer (PFE)/Merck KGaA's label expansion application for Bavencio as a treatment for advanced kidney cancer in combination with Inlyta gets approval in the United States.

Read more from the original source:

Pfizer's Bavencio+Inlyta Combo Gets FDA Nod for Kidney Cancer

Leave a Reply

You must sign in to post a comment.